Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild Cognitive Impairment, Dementia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02266563
What this trial is testing

Amyloid and Tauopathy PET Imaging in Acute and Chronic Traumatic Brain Injury

Who this might be right for
Traumatic Brain InjuryChronic Traumatic EncephalopathyMild Cognitive Impairment
Samuel Gandy 46
Testing effectiveness (Phase 2)Study completedNCT03461276
What this trial is testing

Safety and Immunogenicity of Repeated Doses of ABvac40 in Patients With a-MCI or Vm-AD

Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease
Araclon Biotech S.L. 134
Not applicableLooking for participantsNCT05881239
What this trial is testing

Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD

Who this might be right for
Subjective Cognitive ConcernsMild Cognitive ImpairmentMild Behavioral Impairment+1 more
Massachusetts General Hospital 250
Not applicableUnknownNCT03419039
What this trial is testing

Anthocyanins as Dementia Prevention?

Who this might be right for
DementiaInflammationMild Cognitive Impairment+1 more
Helse Stavanger HF 212
Not applicableEnrolling By InvitationNCT04701177
What this trial is testing

Digitally-enhanced, Decentralized, Multi-omics Observational Cohort

Who this might be right for
Presymptomatic DiseaseMild Cognitive ImpairmentMemory Loss (Excluding Dementia)+4 more
Greece 2021 Committee 100,000
Testing effectiveness (Phase 2)Looking for participantsNCT07012993
What this trial is testing

Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol

Who this might be right for
Alzheimer DiseaseMild Cognitive ImpairmentDementia+1 more
Akiva Mintz 200
Not applicableNot Yet RecruitingNCT05987007
What this trial is testing

Sleep Interventions and Neurocognitive Outcomes

Who this might be right for
Sleep DisturbanceAmnestic Mild Cognitive Impairment
New York State Psychiatric Institute 50
Not applicableActive Not RecruitingNCT06755164
What this trial is testing

Effects of Combined Aerobic and Cognitive Training in a Simultaneous or Sequential Paradigm on Cognition and Brain Functional Activity in Patients with AMCI

Who this might be right for
Mild Cognitive Impairment (MCI)AMCI - Amnestic Mild Cognitive ImpairmentNeurodegenerative Dementia+1 more
IRCCS San Raffaele 55
Large-scale testing (Phase 3)Study completedNCT01662882
What this trial is testing

A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment
Avid Radiopharmaceuticals 48
Not applicableLooking for participantsNCT07289061
What this trial is testing

Positive Psychology for Early Cognitive Decline: Effects on Cognitive and Brain Function

Who this might be right for
Subjective Cognitive Decline (SCD)Mild Cognitive Impairment (MCI)Alzheimer Dementia (AD)
Aristotle University Of Thessaloniki 128
Testing effectiveness (Phase 2)Active Not RecruitingNCT06335173
What this trial is testing

Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)

Who this might be right for
Alzheimer Disease
Acumen Pharmaceuticals 542
Large-scale testing (Phase 3)Looking for participantsNCT07177352
What this trial is testing

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Who this might be right for
Alzheimers Disease
Hoffmann-La Roche 80,000
Not applicableNot Yet RecruitingNCT07422038
What this trial is testing

BioMIND (Biomarkers for the Molecular Identification of Neurodegenerative Dementia) - Improving Access to Alzheimer's Disease Diagnostics: A Pragmatic System Level Intervention

Who this might be right for
Alzheimer Disease (AD)
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 200
Not applicableEnded earlyNCT02612376
What this trial is testing

Rocky Mountain Alzheimer's Disease Center Longitudinal Biomarker and Clinical Phenotyping Study

Who this might be right for
Alzheimer DiseaseDown SyndromeMild Cognitive Impairment
University of Colorado, Denver 800
Not applicableStudy completedNCT06149013
What this trial is testing

Efficacy of MindAhead's Digital Behavioral Activation Therapy in Adults with MCI or Mild Dementia

Who this might be right for
Mild Cognitive ImpairmentMild Dementia
MindAhead UG 50
Not applicableStudy completedNCT02286791
What this trial is testing

Mindful Awareness Program for the Prevention of Dementia: A Randomized Controlled Trial

Who this might be right for
Dementia
National University of Singapore 55
Not applicableEnded earlyNCT01870518
What this trial is testing

Neurocognitive Effects of Bilateral STN Versus GPi DBS in Parkinson's Disease Patients With MCI

Who this might be right for
Parkinson's DiseaseMild Cognitive ImpairmentDementia
St. Joseph's Hospital and Medical Center, Phoenix 13
Early research (Phase 1)Study completedNCT02562989
What this trial is testing

[18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001)

Who this might be right for
Alzheimer's DiseaseAmnestic Mild Cognitive Impairment
Merck Sharp & Dohme LLC 13
Testing effectiveness (Phase 2)Study completedNCT03903211
What this trial is testing

Longitudinal Changes of [18F]PI-2620 Positron Emission Tomography in Subjects With Cognitively Normal, Mild Cognitive Impairment and Alzheimer's Disease

Who this might be right for
Cognitively NormalMild Cognitive ImpairmentAlzheimer Disease
Jae Seung Kim 84
Not applicableActive Not RecruitingNCT03507257
What this trial is testing

Longitudinal Early-onset Alzheimer's Disease Study Protocol

Who this might be right for
Early Onset Alzheimer DiseaseAlzheimer DiseaseMild Cognitive Impairment
Indiana University 850
Next Page